|
Ronald T. Raines, Ph.D., a founder of the Company, is a leading expert on the chemistry and biology of proteins. Dr. Raines serves on the Company's Board of Directors and is a senior member of the Scientific Advisory Board. In these positions, he provides oversight on the scientific direction of the company. As inventor of a number of the technologies licensed exclusively to Quintessence Biosciences, Dr. Raines provides guidance on the development and commercialization of these technologies. Dr. Raines received A.M. and Ph.D. degrees in organic chemistry from Harvard University and did postdoctoral research in biochemistry and biophysics at the University of California, San Francisco. In 1989, he joined the faculty at the University of Wisconsin Madison, where he is now the Henry Lardy Professor of Biochemistry and a Professor of Chemistry. Dr. Raines has served as a Scientific Advisory Board member or consultant for numerous pharmaceutical and biotechnology companies and has been a Visiting Scientist at Chiron Corporation. He is on the Editorial Boards of ACS Chemical Biology and Peptide Science. Dr. Raines is an author of over 200 scientific articles and has won national and international awards for his research, including the 1998 Pfizer Award in Enzyme Chemistry and 2004 Arthur C. Cope Scholar Award from the American Chemical Society, the 2005 Emil Thomas Kaiser Award from the Protein Society, and a 2001 2002 Guggenheim Fellowship. He is a fellow of the American Association for the Advancement of Science and the Royal Society of Chemistry. Dr. Raines is the inventor of the S-TAG technology, which has been licensed by Novagen, Inc.
| 